AustraliaDaily Briefs

Daily Brief Australia: AUB Group Limited, Seven West Media, ETFS FANG+ ETF, Pointerra Ltd, Pro Medicus Ltd and more

In today’s briefing:

  • Private Equity Consortium Eyes AUB Group Buyout Amid Insurance Brokerage Consolidation and Fair Valuation Offer
  • Seven West Media (SWM AU): Scheme Vote on 22 December
  • Primer: ETFS FANG+ ETF (FANG AU) – Nov 2025
  • Pointerra Ltd – Good cost containment in Q1 despite delays
  • Treasure Chest: Pro Medicus


Private Equity Consortium Eyes AUB Group Buyout Amid Insurance Brokerage Consolidation and Fair Valuation Offer

By Special Situation Investments

  • EQT’s A$45/share bid for AUB, with a 16% spread, follows a month of exclusive due diligence.
  • CVC Asia Pacific proposed forming a consortium with EQT, potentially increasing buyout success likelihood and financial commitment sharing.
  • AUB’s valuation metrics include 14.5x FY25 EBITDA and 26.2x P/E, with historical trading at lower multiples.

Seven West Media (SWM AU): Scheme Vote on 22 December

By Arun George

  • The Seven West Media (SWM AU) IE considers the SXL merger offer to be in the best interests of its shareholders, absent a superior proposal.
  • The merger requires approval from SWM shareholders, ACMA, and the ACCC. The ACCC’s findings will be announced on 18 December. 
  • The scheme vote is low risk as large SWM shareholders are supportive. Shares are trading through terms likely due to speculation of a competing bidder, which is unlikely to occur.  

Primer: ETFS FANG+ ETF (FANG AU) – Nov 2025

By αSK

  • The ETFS FANG+ ETF (FANG AU) offers concentrated exposure to 10 of the most highly-traded, technology-focused growth companies.
  • The underlying NYSE FANG+® Index is equally weighted, which differentiates it from market-cap-weighted technology indices and provides a more balanced exposure to its constituents.
  • While the ETF has demonstrated strong historical performance, its concentrated nature and focus on the volatile technology sector present a high-risk, high-reward investment proposition.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Pointerra Ltd – Good cost containment in Q1 despite delays

By Research as a Service (RaaS)

  • Pointerra Ltd (ASX:3DP) provides a powerful cloud-based solution (Pointerra3D) for managing, visualising, analysing, using and sharing massive 3D point clouds and geo-spatial datasets.
  • Pointerra3D is a proprietary digital twin Software-as-a-Service (SaaS) platform which delivers predictive digital insights and definitive answers to complex physical asset management questions.
  • Pointerra has reported Q1 FY26 cash receipts of $1.98m, down 36% on the previous corresponding period (pcp) but up 25% on Q4 FY25.

Treasure Chest: Pro Medicus

By FNArena

  • FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.
  • Today’s idea is Pro Medicus.
  • Brokers reassess Pro Medicus after share price correction Quiet period offsets long-term growth momentum and contract wins AI, cloud certification, and flagship deployments strengthen outlook

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars